- Home
- IOVA vs SAFE Comparison
IOVA vs SAFE Comparison
Compare IOVA & SAFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- SAFE
- Stock Information
- Founded
- IOVA 2007
- SAFE 2016
- Country
- IOVA United States
- SAFE United States
- Employees
- IOVA N/A
- SAFE N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- SAFE Real Estate Investment Trusts
- Sector
- IOVA Health Care
- SAFE Real Estate
- Exchange
- IOVA Nasdaq
- SAFE Nasdaq
- Market Cap
- IOVA 975.1M
- SAFE 1.2B
- IPO Year
- IOVA N/A
- SAFE 2017
- Fundamental
- Price
- IOVA $2.38
- SAFE $16.74
- Analyst Decision
- IOVA Buy
- SAFE Buy
- Analyst Count
- IOVA 11
- SAFE 9
- Target Price
- IOVA $11.90
- SAFE $21.78
- AVG Volume (30 Days)
- IOVA 11.2M
- SAFE 369.6K
- Earning Date
- IOVA 11-06-2025
- SAFE 10-27-2025
- Dividend Yield
- IOVA N/A
- SAFE 4.23%
- EPS Growth
- IOVA N/A
- SAFE N/A
- EPS
- IOVA N/A
- SAFE 1.43
- Revenue
- IOVA $241,525,000.00
- SAFE $393,596,000.00
- Revenue This Year
- IOVA $67.40
- SAFE $0.59
- Revenue Next Year
- IOVA $56.32
- SAFE $5.06
- P/E Ratio
- IOVA N/A
- SAFE $11.70
- Revenue Growth
- IOVA 636.99
- SAFE 2.22
- 52 Week Low
- IOVA $1.64
- SAFE $13.43
- 52 Week High
- IOVA $12.51
- SAFE $28.80
- Technical
- Relative Strength Index (RSI)
- IOVA 49.08
- SAFE 62.51
- Support Level
- IOVA $2.27
- SAFE $15.92
- Resistance Level
- IOVA $2.46
- SAFE $16.55
- Average True Range (ATR)
- IOVA 0.14
- SAFE 0.48
- MACD
- IOVA 0.00
- SAFE 0.03
- Stochastic Oscillator
- IOVA 49.09
- SAFE 98.32
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About SAFE Safehold Inc. New
Safehold Inc is a REIT that operates its business by acquiring, managing, and capitalizing ground leases. Ground leases are long-term contracts between the landlord (the Company) and a tenant or leaseholder. Ground leases generally represent ownership of the land underlying commercial real estate projects that are net leased by the fee owner of the land to the owners/operators of the real estate projects built thereon.